MedTrace Logo

Safety and Efficacy of Intrauterine Biological Barrier on Postoperative Adhesion After Hysteroscopic Adhesiolysis

NCT05475756 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 264

Last updated 2022-07-27

No results posted yet for this study

Summary

To evaluate the safety and efficacy of Intrauterine Biological Barrier developed and produced by Chengdu TopRegMed Medical Technology Co., Ltd on postoperative adhesion after Hysteroscopic Adhesiolysis.

Conditions

  • Intrauterine Adhesion

Interventions

DEVICE

Intrauterine Biological Barrier

after Hysteroscopic adhesiolysis，use of Intrauterine Biological Barrier to repair uterine cavity

DEVICE

Intrauterine Adhesion Barrier Gel

after Hysteroscopic adhesiolysis，use of Intrauterine Adhesion Barrier Gel to repair uterine cavity

Sponsors & Collaborators

  • Zhangzhou Municipal Hospital of Fujian Province

    collaborator OTHER

  • Guangzhou First People's Hospital

    collaborator OTHER

  • Tang-Du Hospital

    collaborator OTHER

  • Suzhou Municipal Hospital

    collaborator OTHER

  • Anhui Provincial Hospital

    collaborator OTHER_GOV

  • Beijing Tiantan Hospital

    lead OTHER

Principal Investigators

  • Limin Feng · Beijing Tiantan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-25
Primary Completion
2024-05-24
Completion
2025-05-23

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05475756 on ClinicalTrials.gov